Trends in lower extremity surgical and endovascular revascularization in Germany;Trends in den chirurgischen und endovaskulären Prozeduren zur Therapie der peripheren arteriellen Verschlusskrankheit in Deutschland

Vasa - Journal of Vascular Diseases

Volumn 40, Issue 5, 2011, Pages 398-403

  Eickmeyer, F ^a   Moysidis, T ^b   Nowak, T ^b   Fifer, B ^c   Santosa, F ^b   Luther, B ^b   Kroger K ^b  

^a HELIOS KLINIKUM KREFELD   (Germany)

^b Helios Klinikum   (Germany)

^c NONE

Author keywords

Atherectomy; Balloon angioplasty; Bypass surgery; Peripheral arterial disease

Indexed keywords

AGED; AORTA RECONSTRUCTION; ARTICLE; ATHERECTOMY; BYPASS SURGERY; ENDOVASCULAR SURGERY; GERMANY; GROUPS BY AGE; HOSPITAL PATIENT; HUMAN; LOWER EXTREMITY ENDOVASCULAR SURGERY; MAJOR CLINICAL STUDY; OPEN SURGICAL PROCEDURE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RECANALIZATION; REVASCULARIZATION;

AGED; ENDOVASCULAR PROCEDURES; GERMANY; HEALTH CARE SURVEYS; HOSPITALS; HUMANS; LOWER EXTREMITY; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 80053342180     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526/a000137     Document Type: Article

References (21)

1. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005; 366: 1925-34.
2. Al-Khoury G, Marone L, Chaer R, Rhee R, Cho J, Leers S, Makaroun M, Gupta N. Isolated femoral endarterectomy: impact of SFA TASC classifi cation on recurrence of symptoms and need for additional intervention. J Vasc Surg. 2009 Oct; 50 (4): 784-9.Epub 2009 Jul 22.
3. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, Ruckley CV, Raab GM; BASIL trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classifi cation. J Vasc Surg. 2010; 51 (5 Suppl): 32S-42S.
4. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, Ruckley CV, Raab GM; BASIL trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received. J Vasc Surg. 2010; 51 (5 Suppl): 18S-31S.
5. Burke CR, Henke PK, Hernandez R, Rectenwald JE, Krishnamurthy V, Englesbe MJ, Kubus JJ, Escobar GA, Upchurch GR Jr, Eliason JL. A contemporary comparison of aortofemoral bypass and aortoiliac stenting in the treatment of aortoiliac occlusive disease. Ann Vasc Surg. 2010; 24: 4-13.
6. Dummit LA. Medicare physician fees: the data behind the numbers. Issue Brief Natl Health Policy Forum. 2010; 838: 1-16.
7. Goodney PP, Beck AW, Nagle J, Welch HG, Zwolak RMa National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg 2009; 50: 54-60.
8. Hynes N, Mahendran B, Manning B, Andrews E, Courtney D, Sultan S. The influence of subintimal angioplasty on level of amputation and limb salvage rates in lower limb critical ischaemia: a 15-year experience. Eur J Vasc Endovasc Surg 2005; 30: 291-9.
9. Ihnat DM, Mills JL Sr. Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes. J Vasc Surg. 2010; 52 (3 Suppl): 92S-95S.
10. Indes JE, Mandawat A, Tuggle CT, Muhs B, Sosa JA. Endovascular procedures for aorto-iliac occlusive disease are associated with superior short-term clinical and economic outcomes compared with open surgery in the inpatient population. J Vasc Surg. 2010; 52: 1173-9
11. Indes JE, Tuggle CT, Mandawat A, Sosa JA. Age-stratifi ed outcomes in elderly patients undergoing open and endovascular procedures for aortoiliac occlusive disease. Surgery. 2010; 148: 420-8.
12. Jain KM, Munn J, Rummel M, Vaddineni S, Longton C. Future of vascular surgery is in the office. J Vasc Surg. 2010; 51: 509-513
13. Lawall H, Diehm C, Pittrow P, Leitlinien zur Diagnostik und Th erapie der peripheren arteriellen Verschlusskrankheit Vasa 2009; 38, S75
14. Norgren L, Hiatt W, Dormandy J, Nehler M, Harris K, Fowkes F. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 (Suppl. 1): S1-S75
15. Regine R, Catalano O, De Siero M, Di Costanzo G, Ragozzino A. Endovascular treatment of femoropopliteal stenoses/occlusions with a SilverHawk directional atherectomy device: immediate results and 12-month follow-up. Radiol Med. 2010; 115: 1208-18
16. Rowe VL, Lee W, Weaver FA, Etzioni D. Patterns of treatment for peripheral arterial disease in the United States: 1996-2005. J Vasc Surg. 2009; 49: 910-7.
17. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, et al. Sustained benefi t at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007; 115: 2745-9.
18. Sixt S, Rastan A, Beschorner U, Noory E, Schwarzwälder U, Bürgelin K, Schwarz T, Müller C, Hauk M, Brantner R, Möhrle C, Linnemann B, Macharzina R, Neumann FJ, Zeller T. Acute and long-term outcome of Silverhawk assisted atherectomy for femoro-popliteal lesions according the TASC II classification: a single-center experience. Vasa. 2010; 39: 229-36.
19. Söderström MI, Arvela EM, Korhonen M, Halmesmäki KH, Albäck AN, Biancari F, Lepäntalo MJ, Venermo MA. Infrapopliteal percutaneous transluminal angioplasty versus bypass surgery as first-line strategies in critical leg ischemia: a propensity score analysis. Ann Surg. 2010; 252: 765-73.
20. Stausberg J. Quality of coding in acute inpatient care. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007; 50: 1039-46.
21. TransAtlantic Inter-Society Working Group. Management of peripheral arterial disease. J Vasc Surg 2000; 31: 168-9